Molecular impact of MinK on the enantiospecific block of IKs by chromanols

被引:62
作者
Lerche, C [1 ]
Seebohm, G
Wagner, CI
Scherer, CR
Dehmelt, L
Abitbol, I
Gerlach, U
Brendel, J
Attali, B
Busch, AE
机构
[1] Aventis Pharma Deutschland GmbH, D-65926 Frankfurt, Germany
[2] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel
关键词
heart; arrhythmia; antiarrhythmics; K channel; delayed rectifier;
D O I
10.1038/sj.bjp.0703734
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Slowly activating I-Ks (KCNQ1/MinK) channels were expressed in Xenopous oocytes and their sensitivity to chromanols was compared to homomeric KCNQ1 channels. To elucidate the contribution of the beta -subunit MinK on chromanol block, a formerly described chromanol HMR 1556 and its enantiomer S5557 were tested for enantio-specificity in blocking I-Ks and KCNQ1 as shown for the single enantiomers of chromanol 293B. Both enantiomers blocked homomeric KCNQ1 channels to a lesser extent than heteromeric I-Ks channels. Furthermore, we expressed both WT and mutant MinK subunits to examine the involvement of particular MinK protein regions in channel block by chromanols. Through a broad variety of MinK deletion and point mutants, we could not identify amino acids or regions where sensitivity was abolished or strikingly diminished (>2.5 fold). This could indicate that MinK does not directly take part in chromanol binding but acts allosterically to facilitate drug binding to the principal subunit KCNQ1.
引用
收藏
页码:1503 / 1506
页数:4
相关论文
共 20 条
[1]   Stilbenes and fenamates rescue the loss of IKS channel function induced by an LQT5 mutation and other IsK mutants [J].
Abitbol, I ;
Peretz, A ;
Lerche, C ;
Busch, AE ;
Attali, B .
EMBO JOURNAL, 1999, 18 (15) :4137-4148
[2]   K(v)LQT1 and IsK (minK) proteins associate to form the I-Ks cardiac potassium current [J].
Barhanin, J ;
Lesage, F ;
Guillemare, E ;
Fink, M ;
Lazdunski, M ;
Romey, G .
NATURE, 1996, 384 (6604) :78-80
[3]   The role of the I-sK protein in the specific pharmacological properties of the I-Ks channel complex [J].
Busch, AE ;
Busch, GL ;
Ford, E ;
Suessbrich, H ;
Lang, HJ ;
Greger, R ;
Kunzelmann, K ;
Attali, B ;
Stuhmer, W .
BRITISH JOURNAL OF PHARMACOLOGY, 1997, 122 (02) :187-189
[4]  
GOGELEIN H, 2000, IN PRESS NAUNYNSCHMI
[5]  
Lees-Miller JP, 2000, MOL PHARMACOL, V57, P367
[6]   Molecular cloning and functional expression of KCNQ5, a potassium channel subunit that may contribute to neuronal M-current diversity [J].
Lerche, C ;
Scherer, CR ;
Seebohm, G ;
Derst, C ;
Wei, AD ;
Busch, AE ;
Steinmeyer, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (29) :22395-22400
[7]  
Lerche C, 2000, BIOPHYS J, V78, p204A
[8]   KvLQT1 potassium channel but not IsK is the molecular target for trans-6-cyano-4-(N-ethylsulfonyl-N-methylamino)-3-hydroxy-2,2-dimethyl-chromane [J].
Loussouarn, G ;
Charpentier, F ;
Mohammad-Panah, R ;
Kunzelmann, K ;
Baró, I ;
Escande, D .
MOLECULAR PHARMACOLOGY, 1997, 52 (06) :1131-1136
[9]   Activation and inactivation of homomeric KvLQT1 potassium channels [J].
Pusch, M ;
Magrassi, R ;
Wollnik, B ;
Conti, F .
BIOPHYSICAL JOURNAL, 1998, 75 (02) :785-792
[10]   Dysfunction of delayed rectifier potassium channels in an inherited cardiac arrhythmia [J].
Sanguinetti, MC .
MOLECULAR AND FUNCTIONAL DIVERSITY OF ION CHANNELS AND RECEPTORS, 1999, 868 :406-413